• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease.

作者信息

Manolis A S, Estes N A

机构信息

Department of Medicine, Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts 02111.

出版信息

Am J Cardiol. 1990 Jan 15;65(3):201-5. doi: 10.1016/0002-9149(90)90085-f.

DOI:10.1016/0002-9149(90)90085-f
PMID:2296889
Abstract

Programmed ventricular stimulation with up to 3 extrastimuli at the right ventricular apex was performed in 52 patients with spontaneous nonsustained ventricular tachycardia (VT) associated with coronary artery disease. There were 44 men and 8 women, aged 66 +/- 9 years (range 45 to 86). The mean left ventricular ejection fraction was 41 +/- 14%. Nonsustained VT was asymptomatic in 10 patients (19%), while the arrhythmia was detected during evaluation of palpitations in 5 patients (10%), presyncope in 11 (21%) and syncope in 26 patients (50%). All patients were tested in the drug-free state and were classified as having no inducible arrhythmia (31 patients, group I), or an inducible arrhythmia (21 patients, group II). The age, gender, type of heart disease, symptoms and left ventricular ejection fraction were similar in both groups. Group I patients had a higher overall incidence of syncope. Group I patients received no therapy, while group II patients received antiarrhythmic therapy guided by electropharmacologic testing. At 21 +/- 17 months there was no sustained VT in either group. There were 3 deaths in group I patients, including 1 sudden, 1 nonsudden cardiac and 1 noncardiac death. In group II patients 6 deaths occurred including 4 nonsudden cardiac and 2 noncardiac deaths. In patients with nonsustained VT and coronary artery disease undergoing programmed ventricular stimulation, the incidence of significant arrhythmic events is low in those without therapy with no inducible arrhythmia, and in those with an inducible arrhythmia with therapy guided by electrophysiologic testing.

摘要

相似文献

1
Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease.
Am J Cardiol. 1990 Jan 15;65(3):201-5. doi: 10.1016/0002-9149(90)90085-f.
2
Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram.器质性心脏病合并非持续性室性心动过速患者的危险分层与管理:程序刺激、左心室射血分数及信号平均心电图的作用
Am J Med. 1990 Jan;88(1N):35N-41N.
3
Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.冠心病患者的非持续性室性心动过速:电生理研究的作用
Circulation. 1987 Jun;75(6):1178-85. doi: 10.1161/01.cir.75.6.1178.
4
Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
Am J Cardiol. 1990 Mar 1;65(9):594-8. doi: 10.1016/0002-9149(90)91036-6.
5
Conversion of sustained into nonsustained ventricular tachycardia during therapy assessment by programmed ventricular stimulation: criterion for a positive drug effect?
Am J Cardiol. 1989 Aug 1;64(5):329-34. doi: 10.1016/0002-9149(89)90529-8.
6
Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
Am J Cardiol. 1990 Oct 15;66(12):947-53. doi: 10.1016/0002-9149(90)90931-p.
7
Management of nonsustained ventricular tachycardia guided by electrophysiological testing.电生理检查指导下的非持续性室性心动过速管理
Pacing Clin Electrophysiol. 1993 May;16(5 Pt 1):1037-50. doi: 10.1111/j.1540-8159.1993.tb04578.x.
8
Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.非持续性室性心动过速和冠心病的轻度症状及无症状患者的风险分层与临床结局:一项前瞻性单中心研究
Am J Cardiol. 1997 Sep 11;80(5B):3F-9F. doi: 10.1016/s0002-9149(97)00478-5.
9
Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.冠状动脉疾病和非持续性室性心动过速患者在程序性心室刺激期间使用异丙肾上腺素的情况。
Am Heart J. 1996 Mar;131(3):516-8. doi: 10.1016/s0002-8703(96)90530-x.
10
Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.针对特发性扩张型心肌病合并非持续性室性心动过速患者进行程序性心室刺激以预测心律失常风险
J Am Coll Cardiol. 1998 Sep;32(3):739-45. doi: 10.1016/s0735-1097(98)00306-4.